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Abstract: The genotoxic and antigenotoxic effects of Aloe vera leaf extract (AV) were investigated using the chromosome
aberrations (CAs) test for the bone marrow cells of rats, sister chromatid exchanges (SCEs) and micronucleus (MN) and
CAs tests for human lymphocytes, and the Ames Salmonella/microsome test system.
In the bone marrow cells of rats, AV extract significantly induced structural and total CAs at all concentrations and in
all treatment periods. In human peripheral lymphocytes, AV did not increase the mean SCE; however, it significantly
induced the MN frequency and structural CAs. In addition, AV showed a cytotoxic effect by decreasing the replication
index (RI), mitotic index (MI), and nuclear division index (NDI) in human lymphocytes and by decreasing the MI in the
bone marrow cells of rats. AV did not decrease the genotoxicity or cytotoxicity of urethane (ethyl carbamate, EC) in the
bone marrow cells of rats or in the mitomycin-C (MMC) in human lymphocytes. AV was a weak mutagen in the TA98
strain of Salmonella typhimurium in the absence of S9mix; however, AV+NPD (4-nitro-o-phenylenediamine) and AV+SA
(sodium azide) exhibited a synergism in increasing the number of revertants for the TA98 and TA100 strains in the
absence of S9mix, respectively.
Key words: Aloe vera, culture of human lymphocytes in vitro, bone marrow cells, rat, Salmonella typhimurium

Aloe vera yaprak ekstraktının in vitro ve in vivo genotoksik ve
anti-genotoksik etkisi
Özet: Aloe vera (AV) yaprak ekstraktının genotoksik ve anti-genotoksik etkileri sıçan kemik iliği hücrelerinde kromozom
aberasyon testi (KA), insan lenfositlerinde kardeş kromatid değişimi, mikronukleus ve KA testleri ve
Ames/Salmonella/mikrozom test sistemleri ile araştırılmıştır.
AV ekstraktı sıçan kemik iliği hücrelerinde uygulanan tüm konsantrasyon ve muamele sürelerinde yapısal ve total
kromozom anormalliklerini önemli düzeyde uyarmıştır. AV, insan lenfositlerinde ortalama kardeş kromatid değişimi
(KKD) sayısını artırmamış, fakat, mikronukleus frekansı ve yapısal kromozom anormalliklerini istatistiksel olarak önemli
düzeyde artırmıştır. AV insan lenfositlerinde replikasyon indeksini (RI), mitotik indeksi (MI) ve nukleus bölünme
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indeksini (NBI) düşürerek, sıçan kemik iliği hücrelerinde ise sadece mitotik indeksi (MI) düşürerek sitotoksik etki
göstermiştir. AV sıçan kemik iliği hücrelerinde üretanın (etil karbamat, EK) insan lenfositlerinde ise mitomisin-C’nin
(MMC) genotoksik ve sitotoksik etkisini düşürmemiştir. AV, Salmonella typhimurium’un TA98 suşu üzerinde S9mix
yokluğunda zayıf mutajenik etki gösterirken, AV+NPD (4-nitro-o-phenylenediamine) ve AV+SA (sodium azide)
karışımları TA98 ve TA100 suşlarında S9mix’in yokluğunda revertantların sayısını sinerjistik olarak artırmıştır.
Anahtar sözcükler: Aloe vera, in vitro insan lenfosit kültürü, kemik iliği hücreleri, Salmonella typhimurium

Introduction
Aloe vera is one of the 432 species of the genus
Aloe belonging to the family Liliaceae. A. vera (L.)
Burm.f. (AV) (synonyms: Aloe barbadensis Mill., Aloe
indica Royle, Aloe perfoliata var. vera L., and Aloe
vulgaris Lam.) is a native plant of southern and
eastern Africa, subsequently introduced into northern
Africa, the Arabian peninsula, China, Gibraltar, the
Mediterranean countries, and the West Indies. The
only medicinal use of AV that is supported by clinical
data is the short-term treatment of occasional
constipation; however, it is widely used in cosmetics
and folk medicine (1-3). According to a WHO report
(1), Aloe vera gel promotes wound healing by directly
stimulating the activity of macrophages and
fibroblasts that increase both collagen and
proteoglycan synthesis, thereby promoting tissue
repair. Furthermore, a complex carbohydrate,
acemannan, which can be isolated from A. vera leaves,
accelerates wound healing and reduces radiationinduced skin reactions. The therapeutic effects of Aloe
vera gel also include the prevention of progressive
dermal ischemia caused by burns, frostbite, electrical
injury, and intraarterial drug abuse (1). It was also
reported that Aloe vera gel acts as an inhibitor of
thromboxane A2, a mediator of progressive tissue
damage (1). AV, as a cosmetic substance, is available in
a large range of skin moisturizers, face and hand
creams, cleansers, soaps, suntan lotions, shampoos
and hair tonics, shaving preparations, bath aids,
makeup and fragrance preparations, and infant
lotions and wipes. In folk medicine, AV is used in the
treatment of seborrheic dermatitis, peptic ulcers,
tuberculosis, and fungal infections, and for reduction
of blood sugar (glucose) levels (1-3). Many recent
studies have focused on the chemical activities of AV
in several test systems. Aloe vera gel is reported to be
effective in reducing the genotoxicity of EMS in the
Drosophila sex-linked recessive lethal test (4). The
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chemopreventive effect of the polysaccharide fraction
isolated from Aloe barbadensis might be associated
with
its
inhibitor
activity
on
BPDEI
(benzo[α]pyrene)-DNA adduct formation in rat
hepatocytes, both in vivo and in vitro (5). In addition,
aloe emodin, a natural constituent of A. vera leaves,
significantly inhibits the growth of Merkel carcinoma
cell lines (6). However, there is no evidence about the
clinical efficacy of topical A. vera applications in
preventing or reducing radiation-induced skin
reactions in cancer patients (7). Furthermore, it has
been reported from analysis of survival fractions,
bacterial transformation, and agarose gel
electrophoresis that Aloe vera leaf pulp extract could
produce single-strand breaks (SSB) in plasmid DNA
in a dose-dependent manner (8). According to recent
data, no study in the literature includes the genotoxic
and antigenotoxic effects of Aloe vera leaf extract
together. Thus, the aim of the present study was to
evaluate the genotoxic and antigenotoxic effects of A.
vera extract by the in vivo and in vitro test systems
using rat bone marrow cells, human peripheral
lymphocytes, and the Salmonella/microsome test
system.
Materials and methods
In the present study, Aloe vera leaf extract was used
as the test substance in in vivo and in vitro tests. The
leaves of Aloe vera were collected on the campus of
Çukurova University in Adana, Turkey. The leaves
were cut from the base of the plant and cleaned, and
the outer layers were removed. The leaves were
homogenized with an Ultra-Turrax homogenizator at
25,000 rpm for 5 min. The pellet was filtered, frozen
in liquid nitrogen at -178 °C, lyophilized at -40 °C and
10-2 torr for 2 days, and stored at 4 °C. The powder
was dissolved in sterile distilled water to obtain the
concentrations that were used in the present study.
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In vivo assay
The assay design was based on OECD Guideline
475, updated and adopted on 21 July 1997, with minor
modifications (9). The in vivo test was performed
according to the method of Topaktaş et al. (10). Young
adult rats of the Sprague-Dawley strain (Rattus
norvegicus var. albinos) were purchased from the
Medical Sciences, Experimental Research and
Application Center of Çukurova University. Four rats
(2 male and 2 female, 12-16 weeks old, weight 210.678
± 1.98 g) were used for each treatment and control.
Plastic cages (32 × 46 × 18 cm) were used for handling
the rats in the Genetics Laboratory. The powdered AV
leaf extracts were dissolved in sterile distilled water.
The rats were intraperitoneally treated with 3 different
concentrations of AV 750, 1000, and 1250 mg/kg b.w.
for 12 and 24 h. To investigate the antigenotoxic effect
of AV against the mutagenicity induced by urethane
(ethyl carbamate, EC), the rats were intraperitoneally
treated with 400 mg/kg b.w. EC and with different
concentrations of AV for 12 and 24 h treatment times.
In the present study, the untreated group (2 male and
2 female rats) was used as the negative control. In
order to arrest metaphase, colchicine (3 mg/kg b.w.,
Sigma C9754) was injected intraperitoneally 2 h
before the animals were sacrificed by cervical
dislocation. The femurs were stripped proximally, and
the bone marrow was aspirated in 4 mL of 0.9% NaCl
(37 °C). The suspension was centrifuged for 10 min
at 1200 rpm, and the bone marrow pellet was
resuspended in 0.4% KCl at 37 °C for 30 min and then
fixed in cold methanol-glacial acetic acid (3:1) for 20
min at room temperature. The treatment with fixative
was repeated 2 times. Then the cells were spread on
glass slides and air-dried. The slides were stained with
Giemsa (5% in Sorensen buffer) for 15 min and 100
well-spread metaphases per animal (a total of 400
metaphases per group) were examined at 1000×
magnification for the occurrence of structural and
numerical CAs. The MI was also determined by
scoring 3000 cells from each animal.
In vitro assay
The methods of Evans (11) and Perry and
Thompson (12) were followed in preparation of CA
and SCE tests, with minor modifications. This study
was conducted according to International Programme
on Chemical Safety (IPCS) guidelines (13).

Whole blood (0.2 mL) from 4 healthy donors (2
males and 2 females, non-smokers, ages 20-24) was
added to 2.5 mL of Chromosome Medium B
(Biochrom, F5023) supplemented with 10 μg/mL of
bromodeoxyuridine (Sigma, B5002). The cultures
were incubated at 37 °C for 72 h. The cells were
treated with 1.25, 2.5, and 5.0 mg/mL concentrations
of AV that had been dissolved in sterile distilled water
for 24 h (AV was added 48 h after initiating the
culture) and 48 h (AV was added 24 h after initiating
the culture). A negative control (untreated cultures)
and a positive control (0.25 μg/mL mitomycin-C
(MMC; Kyowa Hakko Chemical Co., Japan)) were
also used. The cells were exposed to colchicine (0.06
μg/mL, Sigma C9754) for 2 h before harvesting. The
cells were harvested with 0.4% KCl as a hypotonic
solution and methanol-glacial acetic acid (3:1) as a
fixative. The staining of air-dried slides was
performed following the standard method, using 5%
Giemsa stain for CAs and a modified fluorescenceplus-Giemsa method for SCEs (14). The slides were
irradiated with a 30 W, 254 nm UV lamp at 15 cm
distance in Sorensen buffer, then incubated with 1×
SSC (standard saline citrate) at 60 °C for 45-60 min,
and stained with 5% Giemsa prepared with Sorensen
buffer.
The modified methods of Roncada et al. (15) and
Mendelsohn (16) were used for evaluating the
antigenotoxicity of AV. In the present study, MMC
was used as a mutagenic agent. To investigate the
antigenotoxic effect of AV against the mutagenicity
induced by MMC, the cultures were co-treated with
0.25 μg/mL of MMC and with different
concentrations of AV for 24 and 48 h treatment times.
The number of CAs was obtained by calculating
the percentage of metaphases from each
concentration and treatment period that showed
structural and/or numerical alterations. The CAs were
classified according to the International System for
Human Cytogenetic Nomenclature (17). CAs were
evaluated in 100 well-spread metaphases per donor
(in total, 400 metaphases per concentration). Gaps
were not evaluated as CAs, according to Mace et al.
(18). The scoring of SCEs was carried out according to
IPCS guidelines (13) and a total of 100 seconddivision metaphases (25 cells per sample) were
analyzed. The results were used to determine the
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mean number of SCEs (SCE/cell). In addition, a total
of 400 cells (100 cells from each donor) were scored
for replication index (RI). The MI was also
determined by scoring 3000 cells from each donor.
The MI explained the effects of the chemicals on the
G2 stage of the cell cycle, and the RI reflected the
effects of chemicals on the S and G2 stages of the
cycles. The RI was calculated according to the
following formula: RI = (M1 × 1) + (M2 × 2) + (M3 ×
3)/total scored cells. M1, M2, and M3 are the fraction
of cells undergoing the 1st, 2nd, and 3rd mitosis
during the 72 h cell culture period.
For the analysis of micronuclei in binucleated
lymphocytes, 0.2 mL of fresh blood was used to
establish cultures. The cells were treated with 1.25, 2.5,
and 5.0 mg/mL concentrations of AV alone and with
MMC (0.25 μg/mL) for 24 and 48 h treatment
periods.
Cytochalasin B (Sigma, C6762) was added at 44 h
of incubation to a final concentration of 6 μg/mL to
block cytokinesis. After an additional 24 h of
incubation at 37 °C, cells were harvested by
centrifugation and processed for a micronucleus test
of the peripheral lymphocytes (19,20). In all subjects,
2000 binucleated lymphocytes were scored from each
donor (8000 binucleated cells were scored per
concentration). For each donor, a total of 1000 viable
cells were scored to determine the frequency of cells
with 1, 2, 3, or 4 nuclei and to calculate the NDI
(nuclear division index) for the cytotoxicity of AV
using the following formula: NDI = (1 × M1) + (2 ×
M2) + (3 × M3) + (4 × M4)/N, where M1-M4
represent the number of cells with 1-4 nuclei and N is
the total number of viable cells scored (19).
Ames Salmonella/microsome test
Nicotinamide adenine dinucleotide phosphate
(NADP) was purchased from Roche. Glucose-6phosphate (G-6-P) (G7879), DMSO (D8418), Lhistidine (H8125), D-biotin (B4501), ampicillin
(A6140), sodium azide (SA) (S2002), and 2aminofluorene (2-AF) (A9031) were purchased from
Sigma. 4-Nitro-o-phenylenediamine (NPD) was
purchased from Aldrich. The other chemicals, such
as agar (aquamedia, 7178), nutrient broth (NB) (oxoid
B241116), and 3-methylcholanthrene (Oekanal, 200276-4), were also purchased.
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The recommended maximum test concentration
for soluble noncytotoxic substances is 5 mg/plate (21).
Therefore, AV was dissolved in sterile bidistilled water
at the concentrations of 1, 2, 3, 4, and 5 mg/plate. In
this study, 2-AF (dissolved in DMSO), NPD
(dissolved in DMSO), and SA (dissolved in distilled
water) were used as the positive controls.
Albino male rats (Rattus norvegicus var. albinos)
weighing 200 g were pretreated with an 80 mg/kg
concentration of 3-methylcholanthrene (dissolved in
sunflower oil) for 5 days, and the S9 fraction and
S9mix were prepared following the procedure of
Maron and Ames (22). The freshly prepared S9
fraction was distributed in 1 mL portions into small
plastic tubes frozen immediately in crushed dry ice
and stored at 80 °C. The S9mix was prepared fresh for
each mutagenicity assay. For preparation of S9mix,
NADP (4 mM), G-6-P (5 mM), MgCl2 (8 mM), KCl
(33 mM), and 6.2 mL of phosphate buffer (0.2 mM)
were added to 18 mL of sterile bidistilled water
supplemented with 2 mL of microsome fraction (S9);
0.5 mL of S9mix was used for each plate (0.05 mL
S9mix/plate).
Histidine-deficient (his-) tester strains TA98 and
TA100 of Salmonella typhimurium were kindly
provided by Alejandro P. Rooney, ARS Culture
Collection, National Center for Agricultural
Utilization Research, Peoria, Illinois, USA. The TA98
strain was used for the detection of frameshift
mutagens and the TA100 strain was used for the
detection of base-pair substitution mutagens. Prior to
use in the assay, each strain was checked for the
presence of strain-specific markers as described by
Maron and Ames (22).
The standard plate incorporation assay was
examined with Salmonella typhimurium TA98 and
TA100 in the presence or absence of S9mix, according
to the methods of Maron and Ames (22); 0.5 mL of
S9mix per plate was used for the assay. For the
mutagenicity test, AV was dissolved in sterile distilled
water and used in 1, 2, 3, 4, and 5 mg concentrations
per plate. The toxicity of AV to bacteria was observed
based on the significantly reduced number of
revertants compared to the spontaneous control. On
the other hand, NPD (4-nitro-o-phenylenediamine)
and SA (sodium azide) were used as positive
mutagens for TA98 and TA100, respectively. In the
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presence of S9mix, 2-AF (2-aminofluorene) was used
as a positive mutagen for both the TA98 and TA100
strains. Each sample was examined with a 3-plate
count and all experiments were performed twice.
To investigate the antimutagenic effect of A. vera,
the tester strains were treated with both AV and NPD
or both AV and SA for the TA98 and TA100 strains
in the absence of S9mix, respectively. In the presence
of S9mix, 2-AF was used as a positive mutagen for
both strains because 2-AF required a metabolic
activator for the presence of its mutagenic effect.
The t-test was used to determine the statistical
significance of all the parameters. Dose-response
relationships were determined from the correlation
and regression coefficients for the percentage of
structural and total CAs, mean SCEs, MN, RI, MI,
and NDI for in vivo and in vitro test systems. The
significance between control revertants and revertants
of treated groups was determined using the t-test.
Dose-response relationships were determined using
regression and correlation (r) test systems.
Results and discussion
In the bone marrow cells of rats, Aloe vera leaf
extract (AV) significantly induced structural and total
chromosome aberrations (CAs) at all concentrations
and in all treatment periods (Table 1). However, it did
not induce numerical CAs. AV decreased the mitotic
index (MI) at the highest concentration (1250 mg/kg)
for a 12 h treatment period when compared with the
control, but there was no dose-dependent effect. A
similar outcome was noted for the 24 h treatment
period, yet it was statistically significant when
compared to the control. On the other hand, no other
dose-dependent relationships were observed between
concentration ranges and chromosomal aberrations
(Table 1).
AV and EC as a mixture (AV+EC) significantly
induced structural and total CAs at all concentrations
in the 12 and 24 h treatment periods when compared
with the control. In addition, AV+EC induced
structural and total CAs as the positive control means
while AV did not decrease the genotoxicity of EC in
the bone marrow cells of rats (Table 1). AV+EC
significantly decreased the MI in the 12 and 24 h
treatment periods when compared with the control.

In addition, this decrement in the MI was found to be
dose-dependent for the 2 treatment periods (r = -0.99
and r = -0.99, respectively) (Table 1).
AV did not increase the mean sister chromatid
exchange (SCEs/cell) for either treatment period
when compared with the control in the case of human
peripheral lymphocytes (Table 2). Moreover, AV
significantly decreased the RI at the highest
concentration (5 mg/mL) in the 24 h treatment period
and at all concentrations in the 48 h treatment period
without dose-dependency, as compared with the
control.
The 24 and 48 h cotreatments with AV+MMC (AV
and MMC as a mixture) significantly increased the
mean SCEs at all concentrations when compared with
the control in human peripheral lymphocytes (Table
2). This increment showed dose-dependency (r= 1.0
and r = 0.99, respectively). AV+MMC also increased
the mean SCEs of the positive control in the 24 h
treatment period, while AV+MMC significantly
increased the mean SCEs at all concentrations in the
48 h treatment period when compared with MMC
alone. AV+MMC dose-dependency increased the
mean SCEs in both the 24 and 48 h treatment periods
(r = 1.0 and r = 0.99, respectively). AV+MMC
significantly decreased the RI in human peripheral
lymphocytes at all concentrations and in all treatment
periods when compared with the control and with the
positive control, MMC (Table 2).
In human peripheral lymphocytes, AV slightly
induced the micronucleus (MN) frequency in the 24
h treatment period; however, it significantly induced
the MN frequency at all concentrations in the 48 h
treatment period when compared with the control
(Table 3). AV decreased the nuclear division index
(NDI) in the 24 h treatment period when compared
with the control, while it did not decrease the NDI in
the 48 h treatment period (Table 3).
AV+MMC significantly induced the MN
frequency in human peripheral lymphocytes in the 24
h treatment period when compared with the control,
and in the 48 h treatment period as compared with
both the control and the MMC positive control. On
the other hand, AV+MMC caused a significant
reduction in NDI in the 24 and 48 h treatment periods
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Table 1. CAs and MI in the bone marrow cells of rats intraperitoneally treated with AV alone or with AV+EC.
Chromosome Aberrations++

Treatment
Test
+
Substance

Control

Period
(h)

Concentration
(mg/kg)

Structural CAs
B´ type

B˝ type

Numerical
CAs

Structural
CAs/Cell ± SE

Numerical
CAs ± SE (%)

Total CAs/Cell
± SE

MI ± SE

-

-

0

0

0

0.00 ± 0.00

0.00 ± 0.00

0.00 ± 0.00

5.77 ± 0.40

EC

12

400

32

3

0

8.75 ± 2.13

0.00 ± 0.00

8.75 ± 2.13

3.68 ± 0.31

AV

12
12
12

750
1000
1250

13
17
22

1
5
3

3
3
3

3.50 ± 0.86 a1b2
5.50 ± 0.50 a2b2
6.25 ± 1.54 a1

0.75 ± 0.47
0.75 ± 0.75
0.75 ± 0.47

4.25 ± 0.47 a2b2
6.25 ± 1.03 a2
7.00 ± 1.08 a2

5.36 ± 0.60
5.29 ± 0.54
4.59 ± 0.13 a2

AV+EC

12
12
12

750 AV+EC*
1000AV+EC*
1250 AV+EC*

36
24
30

3
1
4

0
1
2

9.75 ± 2.05 a1
6.25 ± 0.94 a2
8.50 ± 1.84 a1

0.00 ± 0.00
0.25 ± 0.25
0.50 ± 0.28

9.75 ± 2.05 a1
6.50 ± 0.86 a2
9.00 ± 1.82 a1

3.72 ± 0.49 a1
3.48 ± 0.29 a1
3.17 ± 0.10 a3b1

EC

24

400

27

5

3

8.00 ± 1.00

0.75 ± 0.47

9.00 ± 1.08

3.81 ± 0.19

AV

24
24
24

750
1000
1250

23
23
23

4
5
4

2
1
1

6.75 ± 1.10 a2
7.00 ± 1.08 a2
6.75 ± 0.75 a2

0.50 ± 0.50
0.25 ± 0.25
0.25 ± 0.25

7.25 ± 1.37 a1
7.25 ± 1.25 a2
7.00 ± 0.70 a2

3.74 ± 0.64
3.70 ± 0.31 a1
3.63 ± 0.32 a1

AV+EC

24
24
24

750 AV+EC*
1000AV+EC*
1250 AV+EC*

37
26
27

5
4
8

1
1
0

10.50 ± 1.19 a2
7.50 ± 0.50 a3
8.75 ± 0.94 a2

0.25 ± 0.25
0.25 ± 0.25
0.00 ± 0.00

10.75 ± 1.10 a2
7.75 ± 0.25 a3
8.75 ± 0.94 a2

3.66 ± 0.32 a1
3.40 ± 0.29 a2
3.20 ± 0.43 a1

*EC (Ethyl carbamate, urethane): 400 mg/kg b.w.
EC: Ethyl carbamate; AV: Aloe vera leaf extract; AV+EC: Mixture of Aloe vera leaf extract and ethyl carbamate
B’ type: Chromatid breakage; B’’ type: Chromosome breakage
a: Significant from control; b: Significant from positive control, EC; a1b1: P < 0.05; a2b2: P < 0.01; a3b3: P < 0.001.

+

++

Table 2. SCEs and RI in human lymphocytes treated with AV alone or with AV and MMC.
Treatment
Test Substance

SCE/Cell ± SE

M1

M2

M3

RI ± SE

0.25 μg/mL

6.23 ± 0.49
29.44 ± 1.02

82
105

118
185

200
110

2.29 ± 0.14
2.01 ± 0.15

24

1.25
2.5
5.0

7.20 ± 0.36 b3
7.99 ± 0.39 a1b3
8.31 ± 1.31 b3

97
104
144

138
149
173

165
147
83

2.17 ± 0.12
2.10 ± 0.15
1.84 ± 0.07a2

AV+MMC

24

1.25 AV+MMC*
2.5 AV+MMC*
5.0 AV+MMC*

32.20 ± 3.01 a2
34.09 ± 3.60 a2
37.90 ± 3.34 a2

184
181
176

149
173
182

67
46
42

1.70 ± 0.03 a3b2
1.66 ± 0.02 a3b3
1.66 ± 0.04 a3b2

MMC

48

0.25 μg/mL

52.00 ± 2.32

129

208

63

1.83 ± 0.07

AV

48

1.25
2.5
5.0

7.20 ± 0.95 b3
8.45 ± 0.96 b3
9.80 ± 1.42 b3

73
68
93

131
130
150

196
202
157

2.30 ± 0.02 b3
2.33 ± 0.05 b2
2.16 ± 0.14

AV+MMC

48

1.25 AV+MMC*
2.5 AV+MMC*
5.0 AV+MMC*

73.11 ± 3.68 a3b1
80.86 ± 9.46 a2b1
93.87 ± 8.96 a2b1

220
223
322

168
171
78

12
6
0

1.48 ± 0.12 a2
1.45 ± 0.09 a2b1
1.19 ± 0.04 a3b3

Period
(h)

Concentration
(mg/mL)

Control
MMC

24

AV

*MMC (mitomycin-C): 0.25 μg/mL
a: Significant from control; b: Significant from positive control, MMC; a1b1: P < 0.05; a2b2: P < 0.01; a3b3: P < 0.001.
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Table 3. MN and NDI in human lymphocytes treated with AV alone or with AV and MMC.
Treatment
Test Substance

MN ± SE(%)

NDI ± SE

-

0.57 ± 0.09

1.38 ± 0.03

24

0.25 μg/mL

1.21 ± 0.27

1.18 ± 0.03

AV

24

1.25
2.5
5.0

0.86 ± 0.12
0.96 ± 0.10 a1
0.66 ± 0.10

1.27 ± 0.03
1.23 ± 0.03 a1
1.20 ± 0.02 a2

AV+MMC

24

1.25 AV+MMC*
2.5 AV+MMC*
5.0 AV+MMC*

1.13 ± 0.30 b1
1.03 ± 0.11 a1
1.46 ± 0.16 a1

1.19 ± 0.01 a3
1.13 ± 0.03 a2
1.10 ± 0.01 a3b1

MMC

48

0.25 μg/mL

6.08 ± 0.50

1.25 ± 0.06

AV

48

1.25
2.5
5.0

1.06 ± 0.13 a1b3
1.11 ± 0.23 a1b3
1.11 ± 0.08 a2b3

1.43 ± 0.09
1.37 ± 0.10
1.21 ± 0.05

AV+MMC

48

1.25 AV+MMC*
2.5 AV+MMC*
5.0 AV+MMC*

11.98 ± 2.32 a1b1
11.78 ± 1.91 a1b1
14.85 ± 3.97 a1b1

1.20 ± 0.03 a1
1.17 ± 0.04 a1
1.12 ± 0.03 a2b1

Period
(h)

Concentration
(mg/mL)

-

MMC

Control

*MMC (mitomycin-C): 0.25 μg/mL
a: Significant from control; b: Significant from positive control, MMC; a1b1: P < 0.05; a2b2: P < 0.01; a3b3: P < 0.001.

when compared with the control. Moreover, this
decrement in NDI for the 48 h treatment period was
in a dose-dependent manner (r = -0.99). In addition,
AV+MMC significantly decreased the NDI at the
highest concentration (5 mg/mL) for the 2 treatment
periods when compared with MMC alone (Table 3).
In human peripheral lymphocytes, AV induced
structural CAs at the highest concentration (5
mg/mL) in only the 48 h treatment period when
compared with the control (Table 4). AV did not
induce numerical CAs (euploidy and aneuploidy) in
human peripheral lymphocytes. Similarly, AV
significantly decreased the MI at the highest
concentration in both the 24 and 48 h treatment
periods. This was shown with dose-dependent effects

in inducing the structural CAs in the 48 h treatment
period (r = 0.99) and in decreasing the MI in the 24 h
treatment period (r = -1.0) (Table 4).
AV+MMC significantly induced structural CAs in
the 24 and 48 h treatment periods in a dosedependent manner when compared with the control
(r = 0.99 and r = 0.99, respectively) (Table 4). On the
other hand, AV+MMC significantly induced
structural CAs in the 48 h treatment period when
compared with the positive control, MMC, which
means that AV showed a synergism with MMC on the
induction of CAs. In addition, AV+MMC
significantly decreased the MI in the 24 and 48 h
treatment periods when compared with the control,
and decreased the MI at the highest concentration in
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Table 4. CAs and MI in human lymphocytes treated with AV alone or with AV and MMC+.
Test Substance

Number of
Structural CAs

Treatment

Structural CAs
± SE(%)**

MI ± SE(%)

Periods
(h)

Concentration
(mg/mL)

B’ type

B’’ type

-

-

8

9

4.25 ± 1.17

4.64 ± 0.75

MMC

24

0.25 μg/mL

43

26

17.25 ± 1.49

3.04 ± 0.45

AV

24

1.25
2.5
5.0

25
22
22

13
4
6

9.50 ± 2.32 b1
6.50 ± 1.32 b2
7.00 ± 2.08 b1

3.58 ± 0.68
3.10 ± 0.57
2.01 ± 0.72 a1

AV+MMC

24

1.25 AV+MMC*
2.5 AV+MMC*
5.0 AV+MMC*

47
55
63***

30
36
40

19.25 ± 2.49 a1
22.75 ± 4.23 a1
34.33 ± 7.21 a1

2.31 ± 0.54 a1
1.76 ± 0.40 a2b1
1.52 ± 0.50 a2b1

MMC

48

0.25 μg/mL

65

49

28.50 ± 6.19

3.74 ± 0.27

AV

48

1.25
2.5
5.0

9
10
27

9
12
6

4.50 ± 1.75 b3
5.50 ± 1.55 b3
8.25 ± 1.18 a1b3

4.70 ± 0.66
4.39 ± 0.64
2.90 ± 0.40 a1

AV+MMC

48

1.25 AV+MMC*
2.5 AV+MMC*
5.0 AV+MMC*

136
160
253

89
100
134

56.25 ± 8.43 a2b1
65.00 ± 8.11 a2b1
97.75 ± 25.57 a1b1

2.93 ± 0.35 a1
2.57 ± 0.74 a1
1.62 ± 0.43 a2b1

Control

+

For abbreviations, see Table 1
*MMC (methyl methanesulfonate): 0.25 μg/mL
**Three polyploid cells were scored and their number was not included in the ratio of structural CAs
***A total of 300 cells were scored due to excessive toxicity
a: Significant from control; b: Significant from positive control, MMC; a1b1: P < 0.05; a2b2: P < 0.01; a3b3: P < 0.001

both treatment periods when compared with MMC.
However, a dose-dependent decrement in MI was
detected only in the 48 h treatment period (r = -0.99)
(Table 4).
AV significantly increased the number of
revertants of the TA98 strain of Salmonella
typhimurium in the absence of S9mix, while AV did
not increase the number of revertants of the TA98
strain in the presence of S9mix or of the TA100 strain
in the absence or presence of S9mix. Furthermore, no
dose-dependent effects were observed (Table 5).
AV+MMC significantly increased the number of
revertants of the TA98 strain in the absence of S9mix
in a dose-dependent manner (r = 0.90) (Table 6).
Similarly, AV+MMC induced the number of
revertants of the TA100 strain in the absence of
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S9mix. This increase was also in a dose-dependent
manner (r = 0.98). There was not a significant
increase in the number of revertants of S.
typhimurium TA98 or TA100 strains in the presence
of S9mix. AV+MMC exhibited a synergism in
increasing the number of revertants for both the TA98
and TA100 strains in the absence of S9mix (Table 6).
In the present experiment, AV, alone or with
positive mutagens (EC or MMC), significantly
induced structural CAs in both in vivo and in vitro
assays. Among these, chromatid-type breaks were the
most common abnormalities. AV did not show
antigenotoxic effects; in contrast, a synergism was
observed between AV and MMC on the induction of
SCEs, MN, and CAs in human lymphocytes. AV,
alone or as a mixture with NPD, showed mutagenic
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Table 5. Mutagenic effects of Aloe vera on S. typhimurium TA98 and TA100 strains.
Test substances

Spontaneous control
+

NPD
2-AF+
SA+

Aloe vera leaf extract

Concentrat.
mg/plate

TA98

TA100

-S9

+S9

-S9

+S9

-

12.50 ± 1.92

20.66 ± 3.42

103.00 ± 9.56

105.25 ± 7.08

200 μg/plate
20 μg/plate
1 μg/plate

3510.0 ± 391.0
-

836.5 ± 45.8
-

758.4 ± 42.9

1347.0 ± 171.4
-

1
2
3
4
5

23.50 ± 2.40 **
15.66 ± 0.76 **
20.66 ± 2.76 *
18.83 ± 2.31 *
15.33 ± 1.05 *

21.50 ± 3.12
22.16 ± 2.41
20.50 ± 2.82
29.16 ± 3.93
22.20 ± 2.81

118.83 ± 5.49 *
106.16 ± 7.17
117.33 ± 4.14 *
109.00 ± 7.34
121.83 ± 10.26

84.25 ± 8.61
92.00 ± 4.37 *
107.25 ± 4.78
92.25 ± 2.21 **
103.75 ± 6.40

Significant from spontaneous control: *P < 0.05; **: P < 0.01; +NPD: 4-nitro-o-phenylenediamine; 2-AF: 2-aminofluorene; SA: sodium
azide

Table 6. Antimutagenic effects of A. vera on S. typhimurium TA98 and TA100 strains.
Test substances

Spontaneous control
+

NPD
2-AF+
SA+
AV+Mutagen

++

Concentrat.
mg/plate

TA98

TA100

-S9

+S9

-S9

+S9

-

15.83 ± 1.13

35.50 ± 5.09

102.66 ± 9.67

141.33 ± 11.05

200 μg/plate
20 μg/plate
1 μg/plate

2586.3 ± 141.7
-

4285.0 ± 1595.0
-

1465.0 ± 49.9

1943.6 ± 129.4
-

1
2
3
4
5

4145.3 ± 296.5**
4992.2 ± 199.9***
6257.1 ± 310.9***
6206.3 ± 112.3***
6332.5 ± 179.1***

NE+
5780.5 ± 330.9*
6528.0 ± 448.8*
5623.5 ± 752.3
5291.0 ± 471.3

1416.8 ± 20.7
1762.3 ± 251.8
2221.8 ± 183.6*
2414.5 ± 291.5*
3168.1 ± 177.1***

NE+
1701.0 ± 234.2
1618.5 ± 158.0
1859.8 ± 235.4
2175.1 ± 177.9

Results were compared with positive controls: *P < 0.05; **:P < 0.01; +NE: Non-evaluated
Positive control substances: NPD: 4-nitro-o-phenylenediamine; 2AF: 2-Aminofluorene; SA: sodium azide
++
To investigate the antimutagenic effect of A. vera, NPD and SA were used for TA98 and TA100 in the absence of S9mix, respectively.
2-AF was used for both strains in the presence of S9mix.
+

activity against the TA98 strain in the absence of
S9mix. In addition, AV+SA synergically induced the
number of revertants of the TA100 strain in the
absence of S9mix.

The most important constituents of the Aloe plant
were anthraquinones like aloin, barbalion, anthranol,
cinnamic acid, aloetic acid, emodin, chrysophanic
acid, resistanol, and enzymes (including
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cyclooxygenase and bradykininase), together with
other compounds such as vitamins, saccharides, and
amino acids (2,23).
Paes-Leme et al. (8) reported that A. vera leaf
extract could produce single-strand breaks (SSB) in
the plasmid DNA of E. coli. Heidemann et al. (24)
reported aloe emodin-induced CAs in CHO cells;
however, no mutagenic potential of aloe emodin was
observed in an in vitro HGPRT test with V79 cells. It
was reported that the other anthraquinones of Aloe
plants had mutagenic and genotoxic effects in
bacterial and mammalian test systems (25,26). In
addition, it was reported that emodin was mutagenic
in S. typhimurium TA1537 and TA98 without S9mix
and mutagenic in the TA1538 strain with and without
S9mix (24,27,28). In the present study, AV
significantly induced the number of revertants of the
TA98 strain in the absence of S9mix. On the other
hand, several studies have reported that Aloe plant
constituents were nonmutagenic and nongenotoxic in
different tests systems using mice, rats, and bacterial
strains (24,26,28,29).
AV caused structural CAs instead of numerical
CAs, which means that AV as a clastogen can trigger
the formation of CAs by breaking the phosphodiester
backbone of DNA. It can be additionally said that AV
induced MN because of its clastogenic effects. It was
reported that anthraquinones bound noncovalently
to DNA and inhibited topoisomerase II activity
(30,31). These data support the idea that inhibition of
catalytic activity of topoisomerase II contributes to
anthraquinone-induced
genotoxicity
and
mutagenicity (31). Furthermore, some chemicals were
reported to act in an insidious fashion and kill cells
by increasing levels of covalent topoisomerase IIcleaved DNA complexes that are normally fleeting
intermediates in the catalytic cycle of the enzyme. All
of these compounds induced concentrationdependent increases in the formation of
topoisomerase II-stabilized cleavage complexes,
providing evidence to support a threshold concept for
clastogenicity with topoisomerase II poisons (32,33).
It might be concluded that AV promotes
chromosomal damage and also acts as a
topoisomerase II poison.
AV was not potent enough to decrease the
mutagenicity of EC in vivo or of MMC in vitro.
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Certain studies indicated that emodin caused gland
carcinomas in rats and adenocarcinoma in mice (13).
In addition, it was reported that powdered or crude
extracts of Aloe plants caused neoplastic and
preneoplastic widespread hemorrhagic lesions in
Syrian hamsters, rats, and mice (34,35), while it was
reported that A. vera extract and anthraquinones like
emodin, alonin, and aloctin showed anticancerogenic
and antigenotoxic activity against certain
cancerogenic substances in animals (4-6,26,36-39).
The anticancerogenic effects of the Aloe plant might
be caused by the cytotoxic properties of these
constituents. According to our results, AV had
cytotoxic effects, decreasing the RI and NDI in human
lymphocytes and the MI in rat bone marrow cells and
human lymphocytes. It was reported that A. vera
extracts emodin and aloe emodin caused cytotoxicity
and induced apoptosis in human cell lines CH27
(human lung squamous carcinoma cell), H460
(human non-small-cell lung carcinoma), HepG2 and
Hep3B (2 human liver cancer cells), neuroectodermal
tumor cells, and mouse lymphoma cells (3,30,40-43).
The cytotoxicity of AV might be caused by the
decreasing ATP level and the pressure from the
functioning of the energy production center (44,45).
On the other hand, it was reported that substances are
capable of causing cytotoxicity by inducing
chromosomal abnormalities and DNA double-strand
breaks (46-50). In this study, AV had a cytotoxic
effect, most probably by inducing structural CAs. In
addition, Madle et al. (51) reported that the mitotic
selection of the cells having chromosome
abnormalities is capable of decreasing the MI.
According to these results, the anticancerogenic effect
of the Aloe plant was probably caused by the mitotic
selection of the cells bearing chromosomal
aberrations. It was reported that A. vera extract caused
external morphological changes, visceral toxicity,
hematological changes, sperm abnormality, and
abortion in rats and mice (34,52).
Conclusion
In this study, AV alone exerted genotoxic and
cytotoxic effects in vivo, in vitro, and in the
Salmonella/microsome test systems. AV also
exhibited a synergism that is capable of increasing the
mutagenic effects of EC and MMC. We therefore
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conclude that AV is a potential mutagen in our
experimental design and should be further examined
in different test systems to better understand its
potential genotoxicity before presentation into public
usage.
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